TCRAX
Price
$63.14
Change
-$0.08 (-0.13%)
Updated
Dec 3 closing price
Net Assets
16.25B
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

TCRAX vs VIGRX

Header iconTCRAX vs VIGRX Comparison
Open Charts TCRAX vs VIGRXBanner chart's image
American Century Growth A
Price$63.14
Change-$0.08 (-0.13%)
VolumeN/A
Net Assets16.25B
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
TCRAX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
TCRAX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TCRAX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. TCRAX (16.3B). VIGRX pays higher dividends than TCRAX: VIGRX (0.30) vs TCRAX (0.00). TCRAX was incepted earlier than VIGRX: TCRAX (29 years) vs VIGRX (33 years). TCRAX (1.22) is less costly to investors than VIGRX (0.17). TCRAX is a more actively managed with annual turnover of: 21.00 vs. VIGRX (11.00). TCRAX has a lower initial minimum investment than VIGRX: TCRAX (2500) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. TCRAX (8.26). VIGRX return over 5 years is better than : 99.11 vs. TCRAX (40.87).
TCRAXVIGRXTCRAX / VIGRX
Total Expense Ratio1.090.17641%
Annual Report Gross Expense Ratio1.220.17718%
Fund Existence29 years33 years-
Gain YTD16.06619.76481%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets16.3B357B5%
Annual Yield % from dividends0.000.30-
Returns for 1 year8.2618.4945%
Returns for 3 years70.05110.8263%
Returns for 5 years40.8799.1141%
Returns for 10 years111.95349.1332%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT